Table 4

Treatment-emergent ocular adverse events in the intervention group in 1 year (mITT)

Participants (n=20)Number of eventsSeverityOutcome
Elevated intraocular pressure4 (20%)5MildRecovered or resolved
Cataract3 (15%)4MildOngoing in two participants; recovered or resolved in one participant (following extraction)
Retinal tear2 (10%)2Mild to moderateRecovered or resolved (following laserpexy)
Eye inflammation2 (10%)6MildRecovered or resolved
Conjunctival cyst1 (5%)1MildRecovered or resolved
Conjunctivitis viral1 (5%)1MildRecovered or resolved
Eye irritation1 (5%)1ModerateRecovered or resolved
Eye pain1 (5%)1MildRecovered or resolved
Eye pruritus1 (5%)1ModerateOngoing
Eye swelling1 (5%)1MildRecovered or resolved
Foreign body sensation in eyes1 (5%)1MildRecovered or resolved
Iritis1 (5%)1MildRecovered or resolved
Macular hole/degeneration1 (5%)2*Mild to moderateRecovered or resolved with sequelae; recovered or resolved
Maculopathy/epiretinal membrane1 (5%)2MildOngoing
Pseudopapilledema1 (5%)1MildRecovered or resolved
Retinal hemorrhage1 (5%)1MildRecovered or resolved

One participant in the control group experienced 1 event of photopsia, which was classified as mild and resolved without sequelae. mITT=modified intention to treat.

*In the same eye of a single subject, a full-thickness macular hole spontaneously resolved (with sequelae) to thinning, which subsequently resolved (without sequelae). This was classified as two adverse events, but occurred in the same clinical course of events.
Disc elevation unrelated to increased intracranial pressure or optic nerve oedema.
-